+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
891494-63-6,MFCD20922873
Catalog No.:AA00GU3N

891494-63-6 | MK-8776 (SCH 900776)

Pack Size
Purity
Availability
Price(USD)
Quantity
  
2mg
98+%
in stock  
$25.00   $18.00
- +
5mg
98+%
in stock  
$41.00   $29.00
- +
10mg
98+%
in stock  
$61.00   $43.00
- +
25mg
98+%
in stock  
$102.00   $71.00
- +
250mg
98+%
in stock  
$492.00   $344.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GU3N
Chemical Name:
MK-8776 (SCH 900776)
CAS Number:
891494-63-6
Molecular Formula:
C15H18BrN7
Molecular Weight:
376.2543
MDL Number:
MFCD20922873
SMILES:
Cn1ncc(c1)c1cnn2c1nc([C@@H]1CCCNC1)c(c2N)Br
Properties
Computed Properties
 
Complexity:
425  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
0.8  

Downstream Synthesis Route

[1]Patent:WO2011/119457,2011,A1.Locationinpatent:Page/Pagecolumn3

[2]TetrahedronLetters,2016,vol.57,p.2601-2603

[3]Patent:WO2013/39854,2013,A1.Locationinpatent:Page/Pagecolumn32;33

[4]Patent:WO2014/62454,2014,A1.Locationinpatent:Page/Pagecolumn36

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

Literature

Title: Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131001

Title: Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20121001

Title: Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors.

Journal: Cell cycle (Georgetown, Tex.) 20120501

Title: Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.

Journal: Molecular cancer therapeutics 20120201

Title: Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.

Journal: Molecular cancer therapeutics 20110401

Title: Montano R, et al. Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites. Mol Cancer Ther. 2012 Feb;11(2):427-38.

Title: Guzi TJ, et al. Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening. Mol Cancer Ther. 2011 Apr;10(4):591-602.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 891494-63-6
Building Blocks
More >
Tags:891494-63-6 Molecular Formula|891494-63-6 MDL|891494-63-6 SMILES|891494-63-6 MK-8776 (SCH 900776)
Catalog No.: AA00GU3N
891494-63-6,MFCD20922873
891494-63-6 | MK-8776 (SCH 900776)
Pack Size： 2mg
Purity： 98+%
in stock
$25.00 $18.00
Pack Size： 5mg
Purity： 98+%
in stock
$41.00 $29.00
Pack Size： 10mg
Purity： 98+%
in stock
$61.00 $43.00
Pack Size： 25mg
Purity： 98+%
in stock
$102.00 $71.00
Pack Size： 250mg
Purity： 98+%
in stock
$492.00 $344.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GU3N
Chemical Name: MK-8776 (SCH 900776)
CAS Number: 891494-63-6
Molecular Formula: C15H18BrN7
Molecular Weight: 376.2543
MDL Number: MFCD20922873
SMILES: Cn1ncc(c1)c1cnn2c1nc([C@@H]1CCCNC1)c(c2N)Br
Properties
Complexity: 425  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 2  
XLogP3: 0.8  
Downstream Synthesis Route
1335211-24-9    891494-63-6 

[1]Patent:WO2011/119457,2011,A1.Locationinpatent:Page/Pagecolumn3

[2]TetrahedronLetters,2016,vol.57,p.2601-2603

[3]Patent:WO2013/39854,2013,A1.Locationinpatent:Page/Pagecolumn32;33

[4]Patent:WO2014/62454,2014,A1.Locationinpatent:Page/Pagecolumn36

25016-11-9    891494-63-6 

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

754159-15-4    891494-63-6 

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

1039364-93-6    891494-63-6 

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

930300-12-2    891494-63-6 

[1]Patent:WO2013/39854,2013,A1

[2]Patent:WO2014/62454,2014,A1

[3]TetrahedronLetters,2016,vol.57,p.2601-2603

[4]TetrahedronLetters,2016,vol.57,p.2601-2603

Literature fold

Title: Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity.

Journal: Toxicological sciences : an official journal of the Society of Toxicology20131001

Title: Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20121001

Title: Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors.

Journal: Cell cycle (Georgetown, Tex.)20120501

Title: Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.

Journal: Molecular cancer therapeutics20120201

Title: Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.

Journal: Molecular cancer therapeutics20110401

Title: Montano R, et al. Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites. Mol Cancer Ther. 2012 Feb;11(2):427-38.

Title: Guzi TJ, et al. Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening. Mol Cancer Ther. 2011 Apr;10(4):591-602.

Related Products of of 891494-63-6
Building Blocks More >
89584-21-4
89584-21-4
4-Amino-3,3-dimethylbutanoic acid hydrochloride
AA00GU7Y | MFCD03813914
89984-45-2
89984-45-2
3-MORPHOLIN-4-YL-3-OXOPROPANETHIOAMIDE
AA00GUBP | MFCD06244880
906820-09-5
906820-09-5
4-Fluoroisoquinoline sulfurate
AA00GUFP | MFCD22377980
880-68-2
880-68-2
1,4-Benzenebisphosphonic acid
AA00GUPE | MFCD00475582
914349-66-9
914349-66-9
3-(Naphthalen-1-yl)thiomorpholine
AA00GUYT | MFCD06797798
881005-34-1
881005-34-1
4-([(Dimethylamino)sulfonyl]amino)benzenesulfonyl chloride
AA00GVB3 | MFCD13188601
906352-57-6
906352-57-6
1-Methyl-1h-benzimidazole-5-carbonyl chloride HCl
AA00GVFZ | MFCD09817460
926219-03-6
926219-03-6
N-(4-amino-2-chlorophenyl)-2-methoxyacetamide
AA00GVKN | MFCD09044588
915920-45-5
915920-45-5
3-(2-Azabicyclo[2.2.1]hept-5-en-2-yl)propan-1-amine
AA00GVP8 | MFCD08752998
938458-56-1
938458-56-1
[2-(Methoxymethoxy)phenyl](pyridin-4-yl)methanone
AA00GVSY | MFCD09055152
Submit
© 2017 AA BLOCKS, INC. All rights reserved.